Video
Journals
Specialty Area
Topics
Institute for Value-Based Medicine
Podcasts
CE
Subscribe
- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Advertisement
Contact Info
2 Commerce Drive
Cranbury, NJ 08512
© 2024 MJH Life Sciences
AJMC®
All rights reserved.
AJMC®
All rights reserved.
Social Burden and Goals of Therapy for Patients with Bronchiectasis
A medical professional addresses the social aspects of bronchiectasis, emphasizing patients' embarrassment due to productive coughing in public spaces like grocery stores and churches, as well as the psychological challenges of planning travel and vacations due to the unpredictability of exacerbations, which can lead to social isolation.
EP: 1.Overview of Bronchiectasis
EP: 2.Prognosis For Patients Diagnosed With Bronchiectasis
EP: 3.Indicators Leading to Bronchiectasis Testing and Diagnosis
EP: 4.Complications Associated With Bronchiectasis
EP: 5.Current Treatment Options For Bronchiectasis
EP: 6.Respiratory and Physical Therapists Contributing to Comprehensive Bronchiectasis Care
EP: 7.Key Areas of Research and Emerging Therapies In Bronchiectasis Treatment
EP: 8.Diagnosing and Understanding the Pathogenesis of Bronchiectasis
EP: 9.Improving Long-Term Outlook: CT Scans and Underdiagnosis of Bronchiectasis
EP: 10.Bronchiectasis Exacerbation Management
EP: 11.Social Burden and Goals of Therapy for Patients with Bronchiectasis
EP: 12.Patient Specific Factors: Guiding Treatment in Bronchiectasis
EP: 13.Individualized Therapy for Specific Infections Associated with Bronchiectasis
EP: 14.Other Challenges With Bronchiectasis and Key Takeaways
EP: 15.Identifying Bronchiectasis: Key Clinical Presentations to Consider
EP: 16.Differentiating Bronchiectasis from COPD and Understanding Exacerbations
EP: 17.Long-Term Impact of Bronchiectasis Exacerbations: Disease Progression, Patient Outcomes, and Economic Burden
EP: 18.Managing Bronchiectasis: Treatment Goals, Outcome Measures, and Clinical Decision Resources
EP: 19.Addressing Knowledge Gaps and Treatment Strategies in Bronchiectasis
EP: 20.Challenges and Future Directions in Bronchiectasis Management
Study Highlights Key RA-ILD Risk Factors, Urges Early Screening
November 20th 2024This recent study highlights key risk factors for rheumatoid arthritis–associated interstitial lung disease (RA-ILD), emphasizing the importance of early screening to improve diagnosis and patient outcomes.
Read More
Breaking the Cycle: The Importance of Early Intervention in Hidradenitis Suppurativa
October 29th 2024Prompt care supports mental well-being, as hidradenitis suppurativa is often associated with depression and anxiety due to its physical and social challenges.
Listen
Why Right Heart Catheterization Confirming PAH Diagnosis May Be Underperformed
November 20th 2024Professional guidelines say that when pulmonary arterial hypertension (PAH) is diagnosed, right heart catheterization should be performed, but a quarter of the time, it isn’t—so investigators set out to discover why.
Read More
Insurance Insights: Dr Jason Shafrin Estimates DMD Insurance Value
July 18th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the July 2024 issue of The American Journal of Managed Care® that estimates the insurance value of novel Duchenne muscular dystrophy (DMD) treatment.
Listen
Influenza Antiviral Treatment Underutilized Among Eligible Children, Adolescents
November 19th 2024Influenza antiviral treatment remains underutilized among eligible children and adolescents, particularly in outpatient settings, despite CDC recommendations.
Read More
New PsA Data Highlight Long-Term Benefits of Bimekizumab
November 19th 2024A trio of abstracts presented at ACR Convergence 2024, the annual meeting of the American College of Rheumatology, bear out the benefits of bimekizumab (Bimzelx; UCB Pharma) for use against active psoriatic arthritis (PsA).
Read More
Study Highlights Key RA-ILD Risk Factors, Urges Early Screening
November 20th 2024This recent study highlights key risk factors for rheumatoid arthritis–associated interstitial lung disease (RA-ILD), emphasizing the importance of early screening to improve diagnosis and patient outcomes.
Read More
Breaking the Cycle: The Importance of Early Intervention in Hidradenitis Suppurativa
October 29th 2024Prompt care supports mental well-being, as hidradenitis suppurativa is often associated with depression and anxiety due to its physical and social challenges.
Listen
Why Right Heart Catheterization Confirming PAH Diagnosis May Be Underperformed
November 20th 2024Professional guidelines say that when pulmonary arterial hypertension (PAH) is diagnosed, right heart catheterization should be performed, but a quarter of the time, it isn’t—so investigators set out to discover why.
Read More
Insurance Insights: Dr Jason Shafrin Estimates DMD Insurance Value
July 18th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the July 2024 issue of The American Journal of Managed Care® that estimates the insurance value of novel Duchenne muscular dystrophy (DMD) treatment.
Listen
Influenza Antiviral Treatment Underutilized Among Eligible Children, Adolescents
November 19th 2024Influenza antiviral treatment remains underutilized among eligible children and adolescents, particularly in outpatient settings, despite CDC recommendations.
Read More
New PsA Data Highlight Long-Term Benefits of Bimekizumab
November 19th 2024A trio of abstracts presented at ACR Convergence 2024, the annual meeting of the American College of Rheumatology, bear out the benefits of bimekizumab (Bimzelx; UCB Pharma) for use against active psoriatic arthritis (PsA).
Read More